Walleye Capital’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.33M Buy
+159,834
New +$5.71M 0.01% 1669
2026
Q2
– Sell
-2,309
Closed -$76.9K – 5163
2026
Q1
$69.5K Buy
+2,309
New +$74.3K ﹤0.01% 3800
2025
Q4
– Sell
-69,150
Closed -$1.7M – 5130
2025
Q3
$1.4M Sell
69,150
-72,041
-51% -$1.27M 0.01% 1839
2025
Q2
$2.37M Sell
141,191
-122,066
-46% -$1.97M 0.01% 1383
2025
Q1
$4.05M Sell
263,257
-745,626
-74% -$13.3M 0.02% 928
2024
Q4
$22.2M Sell
1,008,883
-94,177
-9% -$1.71M 0.05% 298
2024
Q3
$19.9M Buy
1,103,060
+949,026
+616% +$16.6M 0.04% 332
2024
Q2
$2.5M Buy
154,034
+152,639
+10,942% +$2.35M ﹤0.01% 1891
2024
Q1
$19.7K Sell
1,395
-225,056
-99% -$2.84M ﹤0.01% 4933
2023
Q4
$2.36M Buy
226,451
+187,581
+483% +$1.75M 0.01% 1664
2023
Q3
$396K Buy
+38,870
New +$362K ﹤0.01% 2989
2020
Q1
– Sell
-13,752
Closed -$135K – 1638
2019
Q4
$135K Sell
13,752
-136,318
-91% -$1.22M 0.01% 1281
2019
Q3
$1.03M Buy
+150,070
New +$1.15M 0.06% 437
2019
Q2
– Sell
-16,218
Closed -$196K – 2030
2019
Q1
$254K Buy
+16,218
New +$286K 0.04% 672

Other funds holding TEVA

Walleye Capital's TEVA Position: Q3 2026 in Review

Walleye Capital opened a new position in Teva Pharmaceutical Industries (TEVA) in Q3 2026: 159,834 shares worth $6.33M. The stake represents 0.01% of the portfolio and ranks #1669 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TEVA as recently as Q1 2026.

Walleye Capital first reported a position in TEVA in Q1 2019 and has held it in 14 quarters since. The position peaked at $22.2M in Q4 2024. 595 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Walleye Capital held 159,834 shares of Teva Pharmaceutical Industries worth $6.33M as of Q3 2026.
  • Teva Pharmaceutical Industries was a new Walleye Capital position in Q3 2026.
  • Teva Pharmaceutical Industries made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1669 holding.
  • Walleye Capital first reported a position in Teva Pharmaceutical Industries in Q1 2019 and has held it in 14 quarters since.
  • Walleye Capital's Teva Pharmaceutical Industries position peaked at $22.2M in Q4 2024.
  • 595 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.